EMA organises public meeting on COVID-19 vaccines

The EMA will organise a public meeting on 11 December 2020 to inform European citizens about the EU regulatory processes for the approval of COVID-19 vaccines and the Agency’s role in their development, evaluation, approval and safety monitoring. The COVID-19 pandemic is an unprecedented global crisis, with devastating health, social and economic impact. Safe and effective vaccines for COVID-19…

Vaccination Programmes

The European Commission has approved a fifth contract with the European pharmaceutical company CureVac, which provides for the initial purchase of 225 million doses on behalf of all EU Member States, plus an option to request up to a further 180 million doses, to be supplied once a vaccine has proven to be safe and…

EU4 health Programme

To close gaps exposed by COVID-19 and ensure that health systems can face future threats to public health, an ambitious EU health programme is needed, say MEPs. On Friday, Parliament adopted its position on the Commission proposal to step up the EU’s action in the health sector significantly, through the so-called EU4 health programme with…